Issues in trial design for ANCA-associated and large-vessel vasculitis.

about

Issues in trial design for ANCA-associated and large-vessel vasculitis.

Item

http://www.wikidata.org/entity/Q48937679

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Issues in trial design for ANCA-associated and large-vessel vasculitis.

@en

Issues in trial design for ANCA-associated and large-vessel vasculitis.

@nl

type

Item

label

Issues in trial design for ANCA-associated and large-vessel vasculitis.

@en

Issues in trial design for ANCA-associated and large-vessel vasculitis.

@nl

prefLabel

Issues in trial design for ANCA-associated and large-vessel vasculitis.

@en

Issues in trial design for ANCA-associated and large-vessel vasculitis.

@nl

P1476

Issues in trial design for ANCA-associated and large-vessel vasculitis.

@en

P2093

Charles D Pusey

http://www.w3.org/2001/XMLSchema#string

Justin C Mason

http://www.w3.org/2001/XMLSchema#string

Ruth M Tarzi

http://www.w3.org/2001/XMLSchema#string

P2860

Preparing for Responsible Sharing of Clinical Trial Data

Access to Patient-Level Data from GlaxoSmithKline Clinical Trials

The immunopathology of giant cell arteritis: diagnostic and therapeutic implications

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

Genetically distinct subsets within ANCA-associated vasculitis

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.

Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial.

Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials.

Etanercept plus standard therapy for Wegener's granulomatosis.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

P2888

nrrheum.2014.67

P304

502-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRRHEUM.2014.67

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262075394

http://www.w3.org/2001/XMLSchema#string

P698

24798573

http://www.w3.org/2001/XMLSchema#string